F.K. Habib

1.4k total citations
51 papers, 1.1k citations indexed

About

F.K. Habib is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Urology. According to data from OpenAlex, F.K. Habib has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Urology. Recurrent topics in F.K. Habib's work include Prostate Cancer Treatment and Research (17 papers), Hormonal and reproductive studies (14 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). F.K. Habib is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Hormonal and reproductive studies (14 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). F.K. Habib collaborates with scholars based in United Kingdom, United States and Germany. F.K. Habib's co-authors include G. D. CHISHOLM, S. R. Stitch, Michael G. Wyllie, Thomas C. Dembinski, Simon Phipps, S. Alan McNeill, R.L. Reuben, Tao Yang, B. Houston and Margaret Ross and has published in prestigious journals such as Oncogene, FEBS Letters and The Journal of Urology.

In The Last Decade

F.K. Habib

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.K. Habib United Kingdom 19 387 298 240 198 153 51 1.1k
Seiji Ohtani Japan 19 695 1.8× 88 0.3× 71 0.3× 121 0.6× 19 0.1× 42 1.7k
Kyunggon Kim South Korea 24 961 2.5× 127 0.4× 87 0.4× 143 0.7× 22 0.1× 94 1.6k
Yoshinori Okabayashi Japan 24 785 2.0× 84 0.3× 332 1.4× 409 2.1× 8 0.1× 81 1.8k
Chuize Kong China 28 1.5k 3.9× 361 1.2× 57 0.2× 299 1.5× 120 0.8× 134 2.3k
Meng Gu China 22 662 1.7× 295 1.0× 38 0.2× 235 1.2× 154 1.0× 94 1.2k
Ming Lu China 23 1.3k 3.2× 165 0.6× 118 0.5× 217 1.1× 9 0.1× 59 1.9k
Hideto Senzaki Japan 19 533 1.4× 159 0.5× 18 0.1× 224 1.1× 35 0.2× 64 1.3k
Luigi Mele Italy 25 767 2.0× 155 0.5× 30 0.1× 253 1.3× 21 0.1× 62 1.6k
Masanori Kashimata Japan 17 553 1.4× 110 0.4× 75 0.3× 89 0.4× 22 0.1× 70 1.0k

Countries citing papers authored by F.K. Habib

Since Specialization
Citations

This map shows the geographic impact of F.K. Habib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.K. Habib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.K. Habib more than expected).

Fields of papers citing papers by F.K. Habib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.K. Habib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.K. Habib. The network helps show where F.K. Habib may publish in the future.

Co-authorship network of co-authors of F.K. Habib

This figure shows the co-authorship network connecting the top 25 collaborators of F.K. Habib. A scholar is included among the top collaborators of F.K. Habib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.K. Habib. F.K. Habib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Clement, et al.. (2012). Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations. Prostate Cancer and Prostatic Diseases. 15(4). 365–368. 10 indexed citations
2.
Ho, Clement, et al.. (2009). FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men. Prostate Cancer and Prostatic Diseases. 13(1). 94–96. 16 indexed citations
3.
Stewart, Grant D., Richard J.E. Skipworth, Caroline J. Pennington, et al.. (2008). Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines. British Journal of Cancer. 99(1). 126–132. 22 indexed citations
4.
Wu, Daqing, H E Zhau, Wen‐Chin Huang, et al.. (2007). cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene. 26(35). 5070–5077. 112 indexed citations
5.
Phipps, Simon, Tao Yang, F.K. Habib, R.L. Reuben, & S. Alan McNeill. (2005). Measurement of the mechanical characteristics of benign prostatic tissue: A Novel method for assessing benign prostatic disease. Urology. 65(5). 1024–1028. 32 indexed citations
6.
Habib, F.K. & Michael G. Wyllie. (2004). Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract. Prostate Cancer and Prostatic Diseases. 7(3). 195–200. 66 indexed citations
7.
Ross, Michael W., et al.. (2003). MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue. British Journal of Urology. 91(3). 278–283. 27 indexed citations
8.
Olapade‐Olaopa, E. Oluwabunmi, David K. Moscatello, E. Mackay, et al.. (2000). Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer. British Journal of Cancer. 82(1). 186–194. 128 indexed citations
9.
Wolff, J.M., et al.. (1997). Analysis of retinoblastoma gene expression in human prostate tissue. Urologic Oncology Seminars and Original Investigations. 3(5-6). 177–182. 3 indexed citations
10.
Habib, F.K.. (1997). Steroid hormones and cancer: IV prostate cancer. European Journal of Surgical Oncology. 23(3). 264–268. 9 indexed citations
11.
Wolff, J.M., Holger Borchers, W. Boeckmann, F.K. Habib, & G. Jakse. (1997). Increased differentiation between prostate cancer and benign prostatic hyperplasia through measurement of the percentage of free prostate-specific antigen. Der Urologe. 36(3). 255–258. 2 indexed citations
12.
Wolff, J.M., Holger Borchers, Peter J. Effert, F.K. Habib, & G. Jakse. (1996). Free‐to‐total prostate‐specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. British Journal of Urology. 78(3). 409–413. 20 indexed citations
13.
Habib, F.K., G. D. CHISHOLM, Margaret Ross, et al.. (1996). Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia. PubMed. 24(5). 265–271. 18 indexed citations
14.
Wolff, J.M., et al.. (1994). Retinoblastoma and p53 Genes as Prognostic Indicators in Urological Oncology. Urologia Internationalis. 53(1). 1–5. 8 indexed citations
15.
Wolff, J.M. & F.K. Habib. (1993). Tumor suppressor genes in urologic tumors. Urology. 42(4). 461–466. 5 indexed citations
16.
Habib, F.K., et al.. (1992). Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels. Urological Research. 20(4). 281–284. 4 indexed citations
17.
Habib, F.K., et al.. (1990). In vitro Evaluation of the Pollen Extract Cernitin T‐60, in the Regulation of Prostate Cell Growth. British Journal of Urology. 66(4). 393–397. 31 indexed citations
18.
Habib, F.K., et al.. (1990). Characterisation of receptors for 1,25-dihydroxyvitamin D3 in the human testis. Journal of Steroid Biochemistry. 35(2). 195–199. 33 indexed citations
19.
Houston, B., G. D. CHISHOLM, & F.K. Habib. (1985). Evidence that human prostatic 5α‐reductase is located exclusively in the nucleus. FEBS Letters. 185(2). 231–235. 18 indexed citations
20.
Habib, F.K., Geoffrey L. Hammond, S. R. Stitch, & J. B. Dawson. (1975). Proceedings: Testosterone, dihydrotestosterone, zinc and cadmium in prostatic tissue.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 65(3). 34P–34P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026